Graciela Terán

Graciela Terán

Auto-generated profile, based on publicly available information

Graciela Terán

Department of Microbiology, Tumor and Cell Biology (MTC), Biomedicum, Karolinska Institutet, SE-171 65 Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in iScience
Verified
Journal Article
Open access
JZJuan Zhang
Juan Zhang
GTGraciela Terán
Graciela Terán
MPMihaela Popa
Mihaela Popa
HMHarsha Madapura
Harsha Madapura
MLMarcus James Graeme Watson Ladds
Marcus James Graeme Watson Ladds
SDSuhas Darekar
Suhas Darekar
Dihydroorotate dehydrogenase (DHODH) is essential for the de novo synthesis of pyrimidine ribonucleotides, and as such, its inhibitors have been long used to treat autoimmune diseases and are in clinical trials for cancer and viral infections. Interestingly, DHODH is located in the inner mitochondrial membrane and contributes to provide ubiquinol to the respiratory chain. Thus, DHODH provides the link between nucleotide metabolism and mitochondrial function. Here we show that pharmacological inhibition of DHODH reduces mitochondrial respiration, promotes glycolysis, and enhances GLUT4 translocation to the cytoplasmic membrane and that by activating tumor suppressor p53, increases the expression of GDF15, a cytokine that reduces appetite and prolongs lifespan. In addition, similar to the antidiabetic drug metformin, we observed that in db/db mice, DHODH inhibitors elevate levels of circulating GDF15 and reduce food intake. Further analysis using this model for obesity-induced diabetes revealed that DHODH inhibitors delay pancreatic β cell death and improve metabolic balance.

17 May 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
XFXiaogang Feng
Xiaogang Feng
CCCajsa Classon
Cajsa Classon
GTGraciela Terán
Graciela Terán
YYYunlong Yang
Yunlong Yang
LLLei Li
Lei Li
SNSusanne Nylén
Susanne Nylén
Intestinal nematodes suppress immune responses in the context of allergy, gut inflammation, secondary infection and vaccination. Several mechanisms have been proposed for this suppression including alterations in Th2 cell differentiation and increased Treg cell suppressive function. In this study, we show that chronic nematode infection leads to reduced peripheral responses to vaccination because of a generalized reduction in the available responsive lymphocyte pool. We found that superficial skin-draining lymph nodes (LNs) in mice that are chronically infected with the intestinal nematode Heligmosomides polygyrus, do not reach the same cellularity as worm-free mice upon subsequent BCG infection in the skin. B cells and T cells, all declined in skin-draining LN of H. polygyrus-infected mice, resulting in LNs atrophy and altered lymphocyte composition. Importantly, anti-helminthic treatment improved lymphocyte numbers in skin-draining LN, indicating that time after de-worming is critical to regain full-scale LN cellularity. De-worming, and time for the skin LN to recover cellularity, also mended responses to Bacille Calmette-Guerin (BCG) in the LN draining the footpad injection site. Thus, our findings show that chronic nematode infection leads to a paucity of lymphocytes in peripheral lymph nodes, which acts to reduce the efficacy of immune responses at these sites. Infections with intestinal nematodes may be one explanation to why BCG vaccination is less effective in areas of high worm burden. In support of this, we recently showed that chronic intestinal nematode infection resulted in reduced immune responses and higher mycobacterial burden at distal sites. How a gut-dwelling nematode modulate immune responses in skin-draining lymph nodes (LN) was not clear. We found a reduced expansion of LN draining the BCG injected footpad in worm-infected animals, but no evidence for a spread of regulatory cells or cytokines to the BCG-draining LN. Interestingly, we found that mice chronically infected with intestinal worms had significantly smaller skin-draining LN. We propose that the expansion of mesenteric lymph nodes (mLN) occur at the cost of other LN, leading to atrophy of skin-draining LN. Expansion of the lymphocyte pool by IL-7, allowed worm-infected animals to maintain larger skin-draining LN while the mLN did not further expand. De-worming treatment of mice eventually restored the cellularity of skin-draining LN. This, however, took time indicating that effect of worms persisted long after the infection cleared. By de-worming and allowing time for the LN to recover, the cellular responses to BCG injection in the footpad were restored in the draining popliteal LN. Thus, paucity of lymphocytes at peripheral sites can explain impaired peripheral immune responses in worm-infected animals.